C H Sadowsky

Summary

Publications

  1. doi request reprint Switching from donepezil tablets to rivastigmine transdermal patch in Alzheimer's disease
    Carl H Sadowsky
    Nova SE University, Fort Lauderdale, Florida, USA
    Am J Alzheimers Dis Other Demen 24:267-75. 2009
  2. doi request reprint Rivastigmine transdermal system for the treatment of mild to moderate Alzheimer's disease
    G T Grossberg
    St Louis University School of Medicine, St Louis, MO, USA
    Int J Clin Pract 64:651-60. 2010
  3. doi request reprint Guidelines for the management of cognitive and behavioral problems in dementia
    Carl H Sadowsky
    Division of Neurology, Nova Southeastern University, Fort Lauderdale, FL, USA
    J Am Board Fam Med 25:350-66. 2012
  4. doi request reprint Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch
    C Sadowsky
    Department of Neurology, Nova Southeastern University, FL, USA
    CNS Neurosci Ther 16:51-60. 2010
  5. doi request reprint Safety and tolerability of rivastigmine transdermal patch compared with rivastigmine capsules in patients switched from donepezil: data from three clinical trials
    C H Sadowsky
    Nova SE University, Fort Lauderdale, FL, USA
    Int J Clin Pract 64:188-93. 2010

Detail Information

Publications5

  1. doi request reprint Switching from donepezil tablets to rivastigmine transdermal patch in Alzheimer's disease
    Carl H Sadowsky
    Nova SE University, Fort Lauderdale, Florida, USA
    Am J Alzheimers Dis Other Demen 24:267-75. 2009
    ..Evaluate safety and tolerability of switching from donepezil to rivastigmine transdermal patch in patients with mild to moderate Alzheimer's disease...
  2. doi request reprint Rivastigmine transdermal system for the treatment of mild to moderate Alzheimer's disease
    G T Grossberg
    St Louis University School of Medicine, St Louis, MO, USA
    Int J Clin Pract 64:651-60. 2010
    ..The rivastigmine patch provides a viable treatment option for patients with mild to moderate AD...
  3. doi request reprint Guidelines for the management of cognitive and behavioral problems in dementia
    Carl H Sadowsky
    Division of Neurology, Nova Southeastern University, Fort Lauderdale, FL, USA
    J Am Board Fam Med 25:350-66. 2012
    ..Looking forward, there are a number of therapies in development aimed at modifying the disease course; these include amyloid-lowering drugs, τ-based and neuroprotective approaches, acetylcholine agonists, and mitochondrial inhibitors...
  4. doi request reprint Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch
    C Sadowsky
    Department of Neurology, Nova Southeastern University, FL, USA
    CNS Neurosci Ther 16:51-60. 2010
    ..5 mg/24 h patch. This latter regimen is recommended for patients on other oral cholinesterase inhibitors if switching is medically indicated or requested by the patient or the caregiver...
  5. doi request reprint Safety and tolerability of rivastigmine transdermal patch compared with rivastigmine capsules in patients switched from donepezil: data from three clinical trials
    C H Sadowsky
    Nova SE University, Fort Lauderdale, FL, USA
    Int J Clin Pract 64:188-93. 2010
    ..To compare the safety and tolerability of switching patients with mild-to-moderate Alzheimer's disease from donepezil to either rivastigmine capsule or transdermal patch...